CDC recently began reporting data on carbapenemase genes detected through nationwide testing in CDC’s AR Lab Network. Data show that carbapenemase genes, which can make life-saving antibiotics ineffective, were found in only a minority of U.S. isolates. The Containment Strategy must continue to keep these unusual threats from spreading like wildfire. CDC’s AR Lab Network supports nationwide lab capacity to rapidly detect antibiotic resistance and inform local responses to prevent spread and protect people.
The new data are featured in CDC’s Antibiotic Resistance & Patient Safety Portal (AR&PSP), an interactive web-based application that was created to display AR, Use and Stewardship data as well as Healthcare-Associated Infection data for the nation and states.
Additionally, the AR&PSP now includes the number of reported C. difficile infections among hospitalized patients. This includes the number of hospitalized patients with C. difficile infection, including community-onset and hospital-onset infections, across U.S. general acute care hospitals reported in CDC’s National Healthcare Safety Network.
